
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube ( *in collaboration with AbbVie)
The Scientific Director, CMC Quantitative Sciences is a senior technical individual contributor responsible for designing and advancing data-driven development and lifecycle management initiatives for drug products, including knowledge management, through application of advanced statistical analysis, experimental design, and quantitative modeling.
Embedded within Pharmaceutical Development, this role serves as the portfolio-level statistical authority supporting drug product development programs from post-Proof of Concept through regulatory submission and the commercial lifecycle.
In addition to serving as a quantitative authority, this role actively supports formulation and process development strategy by integrating statistical and mechanistic understanding of product design (at first principles-level) to optimize formulations for performance, stability and manufacturability, and strengthen process robustness.
The Director partners cross-functionally with Pharmaceutical & Analytical Development, Quality, Regulatory CMC, and Commercial Manufacturing & Supply Chain to ensure that development and manufacturing decisions are supported by rigorous statistical analysis and defensible interpretation of CMC data.
This role provides technical leadership across multiple development programs, strengthening process understanding, enabling robust control strategies, and improving the quality and regulatory defensibility of CMC submissions.
While embedded in Pharmaceutical Development, the position influences programs spanning late-stage development through commercial lifecycle management and serves as a technical authority and mentor for quantitative approaches across CMC functions.
_
Pharmaceutical Development (CMC)
Owns drug product design and development strategy
Generates, maintains and leverages process understanding and development data
Informs control strategy for regulatory submission and hands-off to commercial
Commercial Manufacturing
Owns routine manufacturing execution and maintains continuity of supply to the market
Owns site-level monitoring and operational performance
Owns CPI/CPV strategy, including design, oversight of execution, monitoring and reporting
Scientific Director, Pharmaceutical Development Quantitative Sciences (This Role)
Provides advanced statistical analysis and modeling expertise across CMC programs
Translates complex development and manufacturing data into actionable technical insights
Ensures statistical rigor and regulatory defensibility of CMC data packages
Serves as a technical authority for statistical interpretation across lifecycle stages
Supports formulation and process development strategies through data-driven insights and mechanistic interpretation
Supports troubleshooting efforts and root-cause investigations as needed on both the formulation and process development fronts for development and commercial assets
Complex Data Interpretation
Apply multivariate tools to support identification of CMAs, CPPs, and design space boundaries
Serve as a technical authority for complex data interpretation across CMC programs
Provide statistical guidance for investigations involving process variability. Support root cause analysis of complex development or manufacturing trends
Integrate datasets across development, analytical, and manufacturing functions to generate actionable insight
Translate experimental data into formulation and process understanding, including identification of critical material attributes, excipient functionality, and process sensitivities
Support development teams in interpreting DoE outcomes to refine formulations and unit operations (e.g., granulation, blending, compression, coating)
Formulation & Process Development Support
Partner with Pharmaceutical Development scientists to design and optimize formulations using structured experimental approaches (DoE, mixture designs, response surface methods)
Provide quantitative and mechanistic input into selection of excipients, formulation composition, and process parameters
Support development and scale-up of key unit operations (e.g., fluid bed granulation, roller compaction, blending, tableting, coating) through data-driven modeling and risk assessment
Guide process characterization strategies, including definition of parameter ranges, interaction effects, and scale dependencies
Contribute to development of robust manufacturing processes by linking material attributes, process parameters, and product performance
Support assessment of formulation and process robustness, including sensitivity analyses and failure mode identification
Regulatory Submission Support
Serve as a primary statistical authority supporting CMC regulatory submissions (NDA, BLA, MAA)
Ensure statistical methodologies used in development and validation are regulatory defensible and aligned with ICH guidelines (Q8, Q9, Q10, Q14)
Provide statistical interpretation for process validation strategies and control strategy justification
Support responses to regulatory questions related to CMC data analysis and statistical methodology
Contribute to justification of formulation composition, process design, and design space within regulatory filings
Capability Building
Strengthen quantitative capabilities across Pharmaceutical Development
Drive adoption of modern data science and modeling approaches that improve development efficiency and process understanding
Establish best practices for experimental design and statistical analysis in development programs
Mentor scientists on statistical thinking and interpretation of experimental results
Promote integration of statistical and formulation/process science to enable more predictive and efficient development approaches
PhD, PharmD, or MS in Statistics, Chemical Engineering, Pharmaceutical Sciences, or related quantitative discipline
12-15+ years of experience applying statistical analysis to pharmaceutical development or manufacturing at all stages of development
Demonstrated expertise in:Design of Experiments (DoE), multivariate analysis, process capability and variability analysis, statistical modeling of manufacturing processes
Working knowledge of formulation principles and solid oral dosage formulation and unit operations (e.g., granulation, blending, encapsulation, compression, coating) required. Hands-on experience is strongly preferred
Experience supporting late-stage development and regulatory submissions (IND/IMPD/CTA/NDA/BLA/MAA)
Proficiency with analytical platforms such as JMP, R, Python, or equivalent statistical tools
Strong ability to influence cross-functional teams through technical expertise and data interpretation
This role:
Act as a portfolio-level technical authority for quantitative approaches throughout the drug product lifecycle. Mentor scientists and strengthen quantitative capabilities within Pharmaceutical Development
Guide experimental design, process characterization, and control strategy development
Actively influence formulation and process development decisions through data-driven and mechanistic insights
Support regulatory submissions (NDA, BLA, MAA) with defensible statistical methodology
Integrate datasets across development, analytical, and manufacturing functions for program-level insight
Provide advanced statistical analysis, modeling, and interpretation across CMC development programs
Translate complex development, analytical, and manufacturing data into actionable technical insights
Ensure statistical rigor and regulatory defensibility of CMC data packages and submissions
Promote adoption of modern data science and modeling approaches to improve efficiency and process understanding
This role does not:
Directly manage or formally supervise staff
Own routine manufacturing execution or site-level operational performance
Serve as program CMC functional area lead, make final operational, business, or budgetary decisions for CMC programs
Manage headcount, administrative processes, or team performance evaluations
Replace hands-on experimental or process work performed by development teams
#LI-DM1
Neurocrine Biosciences is an EEO/Disability/Vets employer.
We are committed to building a workplace of belonging, respect, and empowerment, and we recognize there are a variety of ways to meet our requirements. We are looking for the best candidate for the job and encourage you to apply even if your experience or qualifications don’t line up to exactly what we have outlined in the job description.
_
The annual base salary we reasonably expect to pay is $0.00-$0.00. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of role, job duties/requirements, and relevant experience and skills. In addition, this position offers an annual bonus with a target of 35% of the earned base salary and eligibility to participate in our equity based long term incentive program. Benefits offered include a retirement savings plan (with company match), paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans.

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines
*in collaboration with AbbVie